This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Otopalatodigital syndrome

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Rubinstein-Taybi syndrome (RTS):

  • is a rare disorder characterized by mental and physical retardation, typical facies, and short and broad thumbs and halluces (1)
    • a reported incidence of 1 in 125 000 people
    • also cardiac, neurologic, ocular, and skeletal abnormalities may occur
  • aetiology of RTS has recently been clarified
    • previously this disorder was previously believed to be inherited as X-linked with heterozygous females being more mildly affected (2,3)
    • an autosomal dominant mutation is now believed to be the most probable cause of RTS
      • in studies, many RTS patients have been shown to have molecular mutations or microdeletions of chromosome 16p13.3. This region contains the gene for the human cAMP response element binding (CREB) protein (CBP)
        • CBP is an important regulatory protein within the cell and interacts with a myriad of other such proteins
      • however this mutation or microdeletion is only found in a minority of RTS cases (4-25%) (1)
    • except for rare cases, no phenotype-genotype correlation between RTS patients with or without deletion was detected and therefore normal fluorescent in situ hybridization (FISH) results, do not exclude the diagnosis of RTS (1)
      • in a study by Wallerstein et al (4), growth retardation, nevus flammeus, coloboma, and hypotonia were found to have positive predictive value for the presence of deletion

Reference:

  1. Balci S et al. A 15-year-old boy with Rubinstein-Taybi syndrome associated with severe congenital malalignment of the toenails. Pediatr Dermatol. 2004 Jan-Feb;21(1):44-7.
  2. Marion RW et al. Apparent dominant transmission of the Rubinstein-Taybi syndrome. Am J Med Genet. 1993 May 15;46(3):284-7.
  3. Brewster TG et al.Oto-palato-digital syndrome, type II--an X-linked skeletal dysplasia.Am J Med Genet. 1985 Feb;20(2):249-54.
  4. Wallerstein R, Anderson CE, Hay B, et al. Submicroscopic deletions at 16p13.3 in Rubinstein-Taybi syndrome: frequency and clinical manifestations in a North American population. J Med Genet 1997;34: 203-206.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.